
BCL6-IN-3
CAS No. 2253878-44-1
BCL6-IN-3( —— )
Catalog No. M32800 CAS No. 2253878-44-1
BCL6-IN-3 is a potent BCL6 inhibitor with GI50 of 70 nM in SU-DHL4 cells. BCL6-in-3 regulates cell activation, differentiation, DNA damage and apoptosis, and has antitumor activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 178 | Get Quote |
![]() ![]() |
5MG | 255 | Get Quote |
![]() ![]() |
10MG | 375 | Get Quote |
![]() ![]() |
25MG | 545 | Get Quote |
![]() ![]() |
50MG | 762 | Get Quote |
![]() ![]() |
100MG | 1017 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBCL6-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionBCL6-IN-3 is a potent BCL6 inhibitor with GI50 of 70 nM in SU-DHL4 cells. BCL6-in-3 regulates cell activation, differentiation, DNA damage and apoptosis, and has antitumor activity.
-
DescriptionBCL6-IN-3 is a potent BCL6 inhibitor with GI50 of 70 nM in SU-DHL4 cells. BCL6-in-3 regulates cell activation, differentiation, DNA damage and apoptosis, and has antitumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBCL | DNA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2253878-44-1
-
Formula Weight508.99
-
Molecular FormulaC24H31ClF2N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CC(C)(C)O)N1C=2C(N(C)C1=O)=CC=C(NC3=NC(=NC=C3Cl)N4C[C@H](C)C(F)(F)[C@H](C)C4)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Isoverticine
Isoverticine exhibits significant antitussive, expectorant and anti-inflammatory activities, it also displays significant cytotoxicity.
-
Aromadendrin
Aromadendrin is a natural product.?It induces apoptosis and inhibits Bcl-2 and Bcl-xL expression,?possesses anti-inflammatory, antioxidant, and anti-diabetic properties, it exhibits anti-inflammatory activityAromadendrin, a flavonol, has been reported to possess a variety of pharmacological activities such as anti-inflammatory, antioxidant, and anti-diabetic properties.?
-
BH3I-1
A small-molecule Bcl-2 antagonist that inhibits the ineraction of Bak BH3 and Bcl-xL with Ki of 2.4 uM in FP binding assay.